Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions
NewYork–Presbyterian Hospital · Columbia University Irving Medical Center · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
564
total citations
- FWCI
- 22.21
- Percentile
- 100%
- References
- 68
Citations per year
Authors
13- GWGregg W. StoneCorresponding
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens, Cardiovascular Research Foundation
- DADavid Adams
Mount Sinai Health System
- WTWilliam T. Abraham
The Ohio State University
- APA. Pieter Kappetein
Erasmus MC
- PGPhilippe Généreux
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens, Hôpital du Sacré-Cœur de Montréal, Cardiovascular Research Foundation
Topics & keywords
Topics
Keywords
- Medicine
- Mitral regurgitation
- Clinical trial
- Clinical endpoint
- Mitral valve
- Heart failure
- Intensive care medicine
- Cardiology
No related works found for this paper.